RHENMAN & PARTNERS ASSET MANAGEMENT AB – BioMarin Pharmaceutical Inc. Transaction History
RHENMAN & PARTNERS ASSET MANAGEMENT AB portfolio value:
$20.53M
portfolio value
RHENMAN & PARTNERS ASSET MANAGEMENT AB quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +69.29% | 97K shares | 8.92M | $84.77 | 237K |
| Q2 2022 | share | Decrease | -36.36% | -80K shares | -5.36M | $82.87 | 140K |
| Q1 2022 | share | Decrease | -16.98% | -45K shares | -6.64M | $77.1 | 220K |
| Q4 2021 | share | Increase | +10.42% | 25K shares | 5.05M | $89.08 | 265K |
| Q3 2021 | share | Increase | +50.00% | 80K shares | 5.2M | $77.29 | 240K |
| Q2 2021 | share | Decrease | -11.11% | -20K shares | -242K | $83.44 | 160K |
| Q1 2021 | share | Decrease | -64.71% | -330K shares | -31.13M | $75.51 | 180K |
| Q4 2020 | share | Decrease | -31.48% | -234.35K shares | -11.90M | $87.69 | 510K |
| Q3 2020 | share | Increase | +291.77% | 554.35K shares | 33.19M | $76.08 | 744.35K |
| Q2 2020 | share | Increase | +2.79% | 5.15K shares | 7.81M | $123.34 | 190K |
| Q1 2020 | share | Decrease | -11.98% | -25.15K shares | -2.13M | $84.5 | 184.84K |
| Q4 2019 | share | Decrease | -27.71% | -80.49K shares | -1.82M | $84.55 | 210K |
| Q3 2019 | share | Increase | +3.25% | 9.14K shares | -4.51M | $67.4 | 290.49K |
| Q2 2019 | share | Increase | +21.51% | 49.8K shares | 3.53M | $85.65 | 281.34K |
| Q1 2019 | share | Increase | +31.15% | 55K shares | 5.53M | $88.83 | 231.54K |
| Q4 2018 | share | Decrease | -33.34% | -88.3K shares | -10.64M | $85.15 | 176.54K |
| Q3 2018 | share | Increase | +10.42% | 25K shares | 3.08M | $96.97 | 264.84K |
| Q2 2018 | share | Increase | +17.09% | 35K shares | 5.98M | $94.2 | 239.84K |
| Q1 2018 | share | Increase | +46.48% | 65K shares | 4.13M | $81.07 | 204.84K |
| Q4 2017 | share | Decrease | -22.28% | -40.1K shares | -4.27M | $89.17 | 139.84K |
| Q3 2017 | share | Decrease | -4.94% | -9.35K shares | -444K | $93.07 | 179.94K |
| Q2 2017 | share | Increase | +51.44% | 64.3K shares | 6.21M | $90.82 | 189.3K |
| Q1 2017 | share | Increase | +150.00% | 75K shares | 6.83M | $87.78 | 125K |
| Q4 2016 | share | Decrease | -64.29% | -90K shares | -8.81M | $82.84 | 50K |
| Q3 2016 | share | Decrease | -6.67% | -10K shares | 1.28M | $92.52 | 140K |
| Q2 2016 | share | Decrease | -21.05% | -40K shares | -4.00M | $77.8 | 150K |
| Q1 2016 | share | Increase | +61.02% | 72K shares | 3.30M | $82.48 | 190K |